These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 22328899)

  • 21. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands.
    Harris A; Cox S; Burns D; Norey C
    J Biomol Screen; 2003 Aug; 8(4):410-20. PubMed ID: 14567793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exemplification of the challenges associated with utilising fluorescence intensity based assays in discovery.
    Gul S; Gribbon P
    Expert Opin Drug Discov; 2010 Jul; 5(7):681-90. PubMed ID: 22823207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biophysical screening for the discovery of small-molecule ligands.
    Ciulli A
    Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic cleavage and mass amplification strategy for small molecule detection using aptamer-based fluorescence polarization biosensor.
    Kang L; Yang B; Zhang X; Cui L; Meng H; Mei L; Wu C; Ren S; Tan W
    Anal Chim Acta; 2015 Jun; 879():91-6. PubMed ID: 26002482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of ligands for human LOX-1 through fluorescence polarization-based high throughput screening].
    Zhang TT; Huang ZT; Dai Y; Liu AL; Zhu P; Du GH
    Yao Xue Xue Bao; 2005 Sep; 40(9):792-5. PubMed ID: 16342678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aptamer binding assays and molecular interaction studies using fluorescence anisotropy - A review.
    Zhao Q; Tao J; Feng W; Uppal JS; Peng H; Le XC
    Anal Chim Acta; 2020 Aug; 1125():267-278. PubMed ID: 32674773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence Polarization Assay for Small Molecule Screening of FK506 Biosynthesized in 96-Well Microtiter Plates.
    Ng YZ; Baldera-Aguayo PA; Cornish VW
    Biochemistry; 2017 Oct; 56(40):5260-5268. PubMed ID: 28841306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizations of a novel fluorescence polarization-based high-throughput screening assay for β-catenin/LEF1 interaction inhibitors.
    Chen Y; Fu Z; Li D; Yue Y; Liu X
    Anal Biochem; 2021 Jan; 612():113966. PubMed ID: 32956692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence Polarization Screening Assays for Small Molecule Allosteric Modulators of ABL Kinase Function.
    Grover P; Shi H; Baumgartner M; Camacho CJ; Smithgall TE
    PLoS One; 2015; 10(7):e0133590. PubMed ID: 26222440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of filtration-based time-resolved fluorescence assay for the high-throughput screening of urotensin II receptor antagonist.
    Oh KS; Lee S; Lee BH
    Assay Drug Dev Technol; 2011 Oct; 9(5):514-21. PubMed ID: 21561377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A homogeneous assay of kinase activity that detects phosphopeptide using fluorescence polarization and zinc.
    Scott JE; Carpenter JW
    Anal Biochem; 2003 May; 316(1):82-91. PubMed ID: 12694730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay.
    Cho EJ; Xia S; Ma LC; Robertus J; Krug RM; Anslyn EV; Montelione GT; Ellington AD
    J Biomol Screen; 2012 Apr; 17(4):448-59. PubMed ID: 22223052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput fluorescence polarization assay of ligand binding to IP3 receptors.
    Rossi AM; Taylor CW
    Cold Spring Harb Protoc; 2013 Oct; 2013(10):938-46. PubMed ID: 24086050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-DNA DNA-Encoded Library Affinity Screening.
    Hackler AL; FitzGerald FG; Dang VQ; Satz AL; Paegel BM
    ACS Comb Sci; 2020 Jan; 22(1):25-34. PubMed ID: 31829554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of fluorescence polarization to enzyme assays and single nucleotide polymorphism genotyping: some recent developments.
    Nikiforov TT; Simeonov AM
    Comb Chem High Throughput Screen; 2003 May; 6(3):201-12. PubMed ID: 12678699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK-Paxillin Interaction.
    Marlowe T; Alvarado C; Rivera A; Lenzo F; Nott R; Bondugji D; Montoya J; Hurley A; Kaplan M; Capaldi A; Cance W
    SLAS Discov; 2020 Jan; 25(1):21-32. PubMed ID: 31513463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring 14-3-3 protein interactions with a homogeneous fluorescence polarization assay.
    Du Y; Masters SC; Khuri FR; Fu H
    J Biomol Screen; 2006 Apr; 11(3):269-76. PubMed ID: 16699128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a high-throughput fluorescence polarization assay for the discovery of phosphopantetheinyl transferase inhibitors.
    Duckworth BP; Aldrich CC
    Anal Biochem; 2010 Aug; 403(1-2):13-9. PubMed ID: 20382102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of a high-affinity fluorescent PPARgamma ligand for high-throughput fluorescence polarization assays.
    DeGrazia MJ; Thompson J; Heuvel JP; Peterson BR
    Bioorg Med Chem; 2003 Oct; 11(20):4325-32. PubMed ID: 13129568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.